« Back
Home /
PEAQX tetrasodium hydrate

PEAQX tetrasodium hydrate

Item no.	TMO-T16451-200mg
Manufacturer	TargetMol
CASRN	T16451
Amount	200 mg
Quantity options	100 mg 10 mg 1 mg 200 mg 25 mg 50 mg 5 mg
Category	Reagents & Chemicals Biochemicals
Type	Chemicals
Specific against	other
Formula	C17H15BrN3Na4O6P
Smiles	[O-]P([O-])(C(C1=CC=CC2=C1N=C(C([O-])=N2)[O-])N[C@H](C3=CC=C(C=C3)Br)C)=O.[H]O[H].[Na+].[Na+].[Na+].[Na+]
ECLASS 10.1	32160000
ECLASS 11.0	32160000
UNSPSC	12000000
Alias	NVP-AAM077 tetrasodium hydrate,PEAQX tetrasodium hydrate (459836-30-7 free base),PEAQX tetrasodium hydrate
Shipping Condition	Cool pack
Available
Manufacturer - Targets	Apoptosis\|\|\|NMDAR\|\|\|iGluR
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	560.15
Description	PEAQX tetrasodium hydrate (PEAQX tetrasodium hydrate (459836-30-7 free base)) is an orally available NMDA antagonist that is potent and selective. The IC50 value of PEAQX tetrasodium hydrate (459836-30-7 free base) against hNMDAR 1A/2A was 270 nM and 29600 nM against hNMDAR 1A/2B, respectively.
Pathways	Membrane transporter/Ion channel\|\|\|Apoptosis\|\|\|Neuroscience
Bioactivity	PEAQX tetrasodium hydrate is an effective and orally active NMDA antagonist with a 15-fold preference for human NMDA receptors with the 1A/2A(IC50=270 nM), rather than 1A/2B(29, 600 nM).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T16451-200mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 200 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question